Clinico-pathophysiological considerations in coronary microvascular disorders

Abstract

Around half of the patients undergoing an elective coronary angiogram to investigate typical stable angina symptoms are found to have non-obstructive coronary arteries (defined as < 50% stenosis). These patients are younger with a female predilection. While underlying mechanisms responsible for these presentations are heterogeneous, structural and functional abnormalities of the coronary microvasculature are highly prevalent. Thus, coronary microvascular dysfunction (CMD) is increasingly recognised as an important consideration in patients with non-obstructive coronary arteries. This review will focus on primary coronary microvascular disorders and summarise the four common clinical presentation pictures which can be considered as endotypes - Microvascular Ischaemia (formerly “Syndrome X”), Microvascular Angina, Microvascular Spasm, and Coronary Slow Flow. Furthermore, the pathophysiological mechanisms associated with CMD are also heterogenous. CMD may arise from an increased microvascular resistance, impaired microvascular dilation, and/or inducible microvascular spasm, ultimately causing myocardial ischaemia and angina. Alternatively, chest pain may arise from hypersensitivity of myocardial pain receptors rather than myocardial ischaemia. These two major abnormalities should be considered when assessing an individual clinical picture, and ultimately, the question arises whether to target the heart or the pain perception to treat the anginal symptoms.

Keywords

Coronary microvascular dysfunction / normal coronary angiography / coronary slow flow phenomenon / syndrome X / microvascular angina / microvascular spasm / non-obstructive coronary arteries

References

[1] Patel MR,Dai D.Low diagnostic yield of elective coronary angiography.N Engl J Med2010;362:886-95 PMCID:PMC3920593

[2] Beltrame JF,Camici P.Advances in coronary microvascular dysfunction.Heart Lung Circ2009;18:19-27

[3] Likoff W,Kasparian H.Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease.N Engl J Med1967;276:1063-6

[4] Arbogast R.Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms.Am J Cardiol1973;32:257-63

[5] Kemp HG.Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms.Am J Cardiol1973;32:375-6

[6] Cannon RO.“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries.Am J Cardiol1988;61:1338-43

[7] Cannon RO,Rosing DR.Angina caused by reduced vasodilator reserve of the small coronary arteries.J Am Coll Cardiol1983;1:1359-73

[8] Maseri A,Kaski JC.Mechanisms of angina pectoris in syndrome X.J Am Coll Cardiol1991;17:499-506

[9] Mohri M,Egashira K.Angina pectoris caused by coronary microvascular spasm.Lancet1998;351:1165-9

[10] Tambe A,Zimmerman HA.Angina pectoris and slow flow velocity of dye in coronary arteries - a new angiographic finding.Am Heart J1972;84:66-71

[11] Beltrame JF,Horowitz JD.The coronary slow flow phenomenon - a new coronary microvascular disorder.Cardiology2002;97:197-202

[12] Beltrame JF,Wuttke RD.Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon.Am Heart J2003;146:84-90

[13] Ford TJ,Sidik N.Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders.Circ Cardiovasc Interv2019;12:e008126 PMCID:PMC6924940

[14] Dean J,Mehta PK.Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.Nat Rev Cardiol2015;12:406-14

[15] Suppogu N,Quesada O.Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.Int J Cardiol2021;333:35-9 PMCID:PMC8107128

[16] Radico F,Fulgenzi F.Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis.Eur Heart J2018;39:2135-46

[17] AlBadri A,Johnson BD.Impact of abnormal coronary reactivity on long-term clinical outcomes in women.J Am Coll Cardiol2019;73:684-93 PMCID:PMC6383781

[18] Ong P,Beltrame JF.Coronary Vasomotion Disorders International Study Group (COVADIS)International standardization of diagnostic criteria for microvascular angina.Int J Cardiol2018;250:16-20

[19] Leone MC,Fineschi M.The coronary slow flow phenomenon: a new cardiac "Y" syndrome?.Clin Hemorheol Microcirc2008;39:185-90

[20] Mosseri M,Gotsman MS.Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries.Circulation1986;74:964-72

[21] Kaksi J,Rosano G,Davies G.Role of neuropeptide Y in the pathogenesis of syndrome X.Eur Heart J1992;13:103

[22] Larkin SW,Keogh BE.Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog.Am J Cardiol1989;64:956-8

[23] Hirata K,Akita H,Fukuzaki H.Myocardial ischaemia induced by endothelin in the intact rabbit: angiographic analysis.Cardiovasc Res1990;24:879-83

[24] Pekdemir H,Cin VG.Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow.Int J Cardiol2004;97:35-41

[25] Donato M, Fantini F, Maioli M, Prisco D, Rogasi PG, Neri Serneri GG. Blood velocity in the coronary artery circulation: relation to thromboxane A2 levels in coronary sinus in patients with angiographically normal coronary arteries.Cathet Cardiovasc Diagn1987;13:162-6

[26] Egashira K,Hirooka Y,Urabe Y.Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.N Engl J Med1993;328:1659-64

[27] Camici PG,Lorenzoni R.Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress.J Am Coll Cardiol1991;17:1461-70

[28] Picano E,Masini M,L'abbate A.Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X.Am J Cardiol1987;60:508-12

[29] Picano E.The alternative "ischemic" cascade in coronary microvascular disease.Cardiologia1999;44:791-5

[30] Rosen SD,Wise RJ.Central neural contribution to the perception of chest pain in cardiac syndrome X.Heart2002;87:513-9 PMCID:PMC1767119

[31] Rosen SD,Nihoyannopoulos P.Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia.Ann Intern Med1996;124:939-49

[32] Crea F.Angina pectoris and normal coronary arteries: cardiac syndrome X.Heart2004;90:457-63 PMCID:PMC1768150

[33] Epstein SE,3rd .Exercise testing in patients with microvascular angina.Circulation1991;83:III73-6

[34] Beltrame JF.Defining the coronary slow flow phenomenon.Circ J2012;76:818-20

[35] Shapiro LM,Poole-Wilson PA.Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries?.Br Med J (Clin Res Ed)1988;296:170-1 PMCID:PMC2544901

[36] Cannon RO,Schenke WH.Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries.J Am Coll Cardiol1990;16:1359-66

[37] Chauhan A,Thuraisingham SI,Petch MC.Abnormal cardiac pain perception in syndrome X.J Am Coll Cardiol1994;24:329-35

[38] Pasceri V,Buffon A,Crea F.Role of Abnormal Pain Sensitivity and Behavioral Factors in Determining Chest Pain in Syndrome X.J Am Coll Cardiol1998;31:62-6

[39] Valeriani M,Le Pera D.Abnormal cortical pain processing in patients with cardiac syndrome X.Eur Heart J2005;26:975-82

[40] Lagerqvist B,Waldenström A.Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms.Br Heart J1992;68:282-5 PMCID:PMC1025071

[41] Eriksson B,Martinsson A.Effect of epinephrine infusion on chest pain in syndrome X in the absence of signs of myocardial ischemia.Am J Cardiol1995;75:241-5

[42] Cannon RO 3rd,Mincemoyer R.Imipramine in patients with chest pain despite normal coronary angiograms.N Engl J Med1994;330:1411-7